Metacrine Company

Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases

Total Funding: 173000000
Headquarters: San Diego, California, United States
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Last Funding Type: Debt Financing
Technology: Immunotherapy
Investor Type: IPO
Last Funding Date: 2019
Investors Number: 14
Founded Date: 2015
Industry: Biotechnology, Health Care, Medical, Pharmaceutical